ArticleDiseases (Basel, Switzerland)2024

Therapeutic Effects of Semaglutide on Nonalcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus and Obesity: An Open-Label Controlled Trial.

Ahmed I Gad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.